nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PGD—Dacarbazine—skin cancer	0.712	1	CbGbCtD
Ketotifen—PDE8B—leg—skin cancer	0.0145	0.122	CbGeAlD
Ketotifen—PDE8B—forelimb—skin cancer	0.0144	0.121	CbGeAlD
Ketotifen—PDE8B—hindlimb—skin cancer	0.013	0.109	CbGeAlD
Ketotifen—PDE8B—appendage—skin cancer	0.0111	0.0934	CbGeAlD
Ketotifen—HRH1—nose—skin cancer	0.00681	0.0572	CbGeAlD
Ketotifen—Hepatic enzyme increased—Vismodegib—skin cancer	0.00457	0.0445	CcSEcCtD
Ketotifen—Eyelid oedema—Imiquimod—skin cancer	0.00451	0.0439	CcSEcCtD
Ketotifen—PDE8B—neck—skin cancer	0.00443	0.0372	CbGeAlD
Ketotifen—PDE8A—nipple—skin cancer	0.00403	0.0338	CbGeAlD
Ketotifen—PDE7A—lymphoid tissue—skin cancer	0.00334	0.028	CbGeAlD
Ketotifen—PDE7A—female reproductive system—skin cancer	0.00322	0.027	CbGeAlD
Ketotifen—Tingling sensation—Imiquimod—skin cancer	0.00283	0.0276	CcSEcCtD
Ketotifen—Stinging—Imiquimod—skin cancer	0.00281	0.0273	CcSEcCtD
Ketotifen—PDE7A—head—skin cancer	0.00269	0.0226	CbGeAlD
Ketotifen—PGD—nipple—skin cancer	0.00245	0.0206	CbGeAlD
Ketotifen—PGD—neck—skin cancer	0.00242	0.0203	CbGeAlD
Ketotifen—Hepatic enzyme increased—Imiquimod—skin cancer	0.00241	0.0234	CcSEcCtD
Ketotifen—PDE8A—mammalian vulva—skin cancer	0.00235	0.0198	CbGeAlD
Ketotifen—PDE7B—head—skin cancer	0.00235	0.0197	CbGeAlD
Ketotifen—PDE8B—female reproductive system—skin cancer	0.00224	0.0188	CbGeAlD
Ketotifen—PDE4B—nipple—skin cancer	0.00193	0.0162	CbGeAlD
Ketotifen—PDE8B—head—skin cancer	0.00187	0.0157	CbGeAlD
Ketotifen—PGD—connective tissue—skin cancer	0.00174	0.0146	CbGeAlD
Ketotifen—PDE4C—head—skin cancer	0.00173	0.0145	CbGeAlD
Ketotifen—PDE7B—lymph node—skin cancer	0.00165	0.0138	CbGeAlD
Ketotifen—Cystitis noninfective—Bleomycin—skin cancer	0.00158	0.0154	CcSEcCtD
Ketotifen—Irritability—Imiquimod—skin cancer	0.00158	0.0154	CcSEcCtD
Ketotifen—PGD—skin of body—skin cancer	0.00157	0.0132	CbGeAlD
Ketotifen—Tingling sensation—Fluorouracil—skin cancer	0.00156	0.0152	CcSEcCtD
Ketotifen—Cystitis—Bleomycin—skin cancer	0.00156	0.0152	CcSEcCtD
Ketotifen—Stinging—Fluorouracil—skin cancer	0.00155	0.0151	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00148	0.0144	CcSEcCtD
Ketotifen—Bladder pain—Bleomycin—skin cancer	0.00146	0.0142	CcSEcCtD
Ketotifen—Hepatic enzyme increased—Temozolomide—skin cancer	0.00144	0.014	CcSEcCtD
Ketotifen—PGD—mammalian vulva—skin cancer	0.00143	0.012	CbGeAlD
Ketotifen—Pain—Vismodegib—skin cancer	0.00132	0.0128	CcSEcCtD
Ketotifen—PDE8B—lymph node—skin cancer	0.00131	0.011	CbGeAlD
Ketotifen—PGD—lymphoid tissue—skin cancer	0.00127	0.0107	CbGeAlD
Ketotifen—Erythema multiforme—Vemurafenib—skin cancer	0.00127	0.0123	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00126	0.0123	CcSEcCtD
Ketotifen—Gastrointestinal pain—Vismodegib—skin cancer	0.00126	0.0123	CcSEcCtD
Ketotifen—Dry eye—Temozolomide—skin cancer	0.00126	0.0123	CcSEcCtD
Ketotifen—PGD—female reproductive system—skin cancer	0.00123	0.0103	CbGeAlD
Ketotifen—Abdominal pain—Vismodegib—skin cancer	0.00122	0.0119	CcSEcCtD
Ketotifen—PDE8A—lymph node—skin cancer	0.00118	0.0099	CbGeAlD
Ketotifen—PDE4B—mammalian vulva—skin cancer	0.00113	0.00945	CbGeAlD
Ketotifen—HRH1—nipple—skin cancer	0.00111	0.0093	CbGeAlD
Ketotifen—Pruritus—Vismodegib—skin cancer	0.00109	0.0106	CcSEcCtD
Ketotifen—Erythema multiforme—Imiquimod—skin cancer	0.00108	0.0105	CcSEcCtD
Ketotifen—PDE4D—lymph node—skin cancer	0.00107	0.00897	CbGeAlD
Ketotifen—Diarrhoea—Vismodegib—skin cancer	0.00106	0.0103	CcSEcCtD
Ketotifen—PGD—head—skin cancer	0.00102	0.00859	CbGeAlD
Ketotifen—PDE4B—lymphoid tissue—skin cancer	0.001	0.00839	CbGeAlD
Ketotifen—Vomiting—Vismodegib—skin cancer	0.000981	0.00954	CcSEcCtD
Ketotifen—Rash—Vismodegib—skin cancer	0.000973	0.00946	CcSEcCtD
Ketotifen—Dermatitis—Vismodegib—skin cancer	0.000972	0.00945	CcSEcCtD
Ketotifen—PDE4B—female reproductive system—skin cancer	0.000964	0.00809	CbGeAlD
Ketotifen—Infection—Vemurafenib—skin cancer	0.000947	0.00921	CcSEcCtD
Ketotifen—PDE4A—lymph node—skin cancer	0.000946	0.00794	CbGeAlD
Ketotifen—Nausea—Vismodegib—skin cancer	0.000916	0.00891	CcSEcCtD
Ketotifen—Syncope—Imiquimod—skin cancer	0.000893	0.00869	CcSEcCtD
Ketotifen—Loss of consciousness—Imiquimod—skin cancer	0.000875	0.00851	CcSEcCtD
Ketotifen—Irritability—Fluorouracil—skin cancer	0.000872	0.00848	CcSEcCtD
Ketotifen—Hypertension—Imiquimod—skin cancer	0.00086	0.00836	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000837	0.00814	CcSEcCtD
Ketotifen—Dry mouth—Imiquimod—skin cancer	0.000829	0.00806	CcSEcCtD
Ketotifen—Infection—Imiquimod—skin cancer	0.000808	0.00785	CcSEcCtD
Ketotifen—PDE4B—head—skin cancer	0.000805	0.00676	CbGeAlD
Ketotifen—Shock—Imiquimod—skin cancer	0.0008	0.00778	CcSEcCtD
Ketotifen—HRH1—connective tissue—skin cancer	0.000786	0.0066	CbGeAlD
Ketotifen—Weight increased—Temozolomide—skin cancer	0.00078	0.00758	CcSEcCtD
Ketotifen—Hepatitis—Dactinomycin—skin cancer	0.000758	0.00737	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000757	0.00736	CcSEcCtD
Ketotifen—Body temperature increased—Vemurafenib—skin cancer	0.000753	0.00733	CcSEcCtD
Ketotifen—HRH1—epithelium—skin cancer	0.000746	0.00626	CbGeAlD
Ketotifen—Insomnia—Imiquimod—skin cancer	0.000735	0.00715	CcSEcCtD
Ketotifen—Paraesthesia—Imiquimod—skin cancer	0.00073	0.0071	CcSEcCtD
Ketotifen—Somnolence—Imiquimod—skin cancer	0.000723	0.00703	CcSEcCtD
Ketotifen—PGD—lymph node—skin cancer	0.000717	0.00601	CbGeAlD
Ketotifen—Erythema multiforme—Dactinomycin—skin cancer	0.000717	0.00697	CcSEcCtD
Ketotifen—Pain—Imiquimod—skin cancer	0.000695	0.00676	CcSEcCtD
Ketotifen—Hepatitis—Temozolomide—skin cancer	0.000686	0.00667	CcSEcCtD
Ketotifen—Pruritus—Vemurafenib—skin cancer	0.000674	0.00656	CcSEcCtD
Ketotifen—Gastrointestinal pain—Imiquimod—skin cancer	0.000665	0.00646	CcSEcCtD
Ketotifen—Epistaxis—Fluorouracil—skin cancer	0.000664	0.00645	CcSEcCtD
Ketotifen—Diarrhoea—Vemurafenib—skin cancer	0.000652	0.00634	CcSEcCtD
Ketotifen—Erythema multiforme—Temozolomide—skin cancer	0.000648	0.0063	CcSEcCtD
Ketotifen—HRH1—mammalian vulva—skin cancer	0.000647	0.00543	CbGeAlD
Ketotifen—Urticaria—Imiquimod—skin cancer	0.000646	0.00628	CcSEcCtD
Ketotifen—Abdominal pain—Imiquimod—skin cancer	0.000643	0.00625	CcSEcCtD
Ketotifen—Body temperature increased—Imiquimod—skin cancer	0.000643	0.00625	CcSEcCtD
Ketotifen—Dizziness—Vemurafenib—skin cancer	0.00063	0.00613	CcSEcCtD
Ketotifen—Vomiting—Vemurafenib—skin cancer	0.000606	0.00589	CcSEcCtD
Ketotifen—Rash—Vemurafenib—skin cancer	0.000601	0.00584	CcSEcCtD
Ketotifen—Dermatitis—Vemurafenib—skin cancer	0.0006	0.00584	CcSEcCtD
Ketotifen—Headache—Vemurafenib—skin cancer	0.000597	0.00581	CcSEcCtD
Ketotifen—Pruritus—Imiquimod—skin cancer	0.000575	0.00559	CcSEcCtD
Ketotifen—Infection—Bleomycin—skin cancer	0.000574	0.00558	CcSEcCtD
Ketotifen—Nausea—Vemurafenib—skin cancer	0.000566	0.00551	CcSEcCtD
Ketotifen—Thrombocytopenia—Bleomycin—skin cancer	0.000565	0.0055	CcSEcCtD
Ketotifen—PDE4B—lymph node—skin cancer	0.000564	0.00473	CbGeAlD
Ketotifen—Diarrhoea—Imiquimod—skin cancer	0.000556	0.00541	CcSEcCtD
Ketotifen—HRH1—female reproductive system—skin cancer	0.000554	0.00465	CbGeAlD
Ketotifen—Dizziness—Imiquimod—skin cancer	0.000537	0.00523	CcSEcCtD
Ketotifen—Infection—Dactinomycin—skin cancer	0.000535	0.0052	CcSEcCtD
Ketotifen—Thrombocytopenia—Dactinomycin—skin cancer	0.000527	0.00513	CcSEcCtD
Ketotifen—Paraesthesia—Bleomycin—skin cancer	0.000519	0.00504	CcSEcCtD
Ketotifen—Weight increased—Docetaxel—skin cancer	0.000518	0.00504	CcSEcCtD
Ketotifen—Vomiting—Imiquimod—skin cancer	0.000517	0.00503	CcSEcCtD
Ketotifen—Hypertension—Temozolomide—skin cancer	0.000515	0.00501	CcSEcCtD
Ketotifen—Rash—Imiquimod—skin cancer	0.000512	0.00498	CcSEcCtD
Ketotifen—Dermatitis—Imiquimod—skin cancer	0.000512	0.00498	CcSEcCtD
Ketotifen—Headache—Imiquimod—skin cancer	0.000509	0.00495	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000504	0.0049	CcSEcCtD
Ketotifen—Dry mouth—Temozolomide—skin cancer	0.000497	0.00483	CcSEcCtD
Ketotifen—Pain—Bleomycin—skin cancer	0.000494	0.0048	CcSEcCtD
Ketotifen—Infection—Temozolomide—skin cancer	0.000484	0.00471	CcSEcCtD
Ketotifen—Nausea—Imiquimod—skin cancer	0.000483	0.0047	CcSEcCtD
Ketotifen—Epistaxis—Docetaxel—skin cancer	0.000479	0.00466	CcSEcCtD
Ketotifen—Thrombocytopenia—Temozolomide—skin cancer	0.000477	0.00464	CcSEcCtD
Ketotifen—HRH1—head—skin cancer	0.000463	0.00389	CbGeAlD
Ketotifen—Pain—Dactinomycin—skin cancer	0.000461	0.00448	CcSEcCtD
Ketotifen—Urticaria—Bleomycin—skin cancer	0.000459	0.00446	CcSEcCtD
Ketotifen—Body temperature increased—Bleomycin—skin cancer	0.000456	0.00444	CcSEcCtD
Ketotifen—Hepatitis—Docetaxel—skin cancer	0.000456	0.00443	CcSEcCtD
Ketotifen—Infection—Fluorouracil—skin cancer	0.000446	0.00434	CcSEcCtD
Ketotifen—Insomnia—Temozolomide—skin cancer	0.000441	0.00428	CcSEcCtD
Ketotifen—Gastrointestinal pain—Dactinomycin—skin cancer	0.00044	0.00428	CcSEcCtD
Ketotifen—Thrombocytopenia—Fluorouracil—skin cancer	0.000439	0.00427	CcSEcCtD
Ketotifen—Paraesthesia—Temozolomide—skin cancer	0.000437	0.00425	CcSEcCtD
Ketotifen—Somnolence—Temozolomide—skin cancer	0.000433	0.00421	CcSEcCtD
Ketotifen—Erythema multiforme—Docetaxel—skin cancer	0.000431	0.00419	CcSEcCtD
Ketotifen—Abdominal pain—Dactinomycin—skin cancer	0.000426	0.00414	CcSEcCtD
Ketotifen—Body temperature increased—Dactinomycin—skin cancer	0.000426	0.00414	CcSEcCtD
Ketotifen—Pain—Temozolomide—skin cancer	0.000417	0.00405	CcSEcCtD
Ketotifen—Pruritus—Bleomycin—skin cancer	0.000409	0.00397	CcSEcCtD
Ketotifen—Insomnia—Fluorouracil—skin cancer	0.000406	0.00395	CcSEcCtD
Ketotifen—Paraesthesia—Fluorouracil—skin cancer	0.000403	0.00392	CcSEcCtD
Ketotifen—Somnolence—Fluorouracil—skin cancer	0.000399	0.00388	CcSEcCtD
Ketotifen—Gastrointestinal pain—Temozolomide—skin cancer	0.000398	0.00387	CcSEcCtD
Ketotifen—Urticaria—Temozolomide—skin cancer	0.000387	0.00376	CcSEcCtD
Ketotifen—Abdominal pain—Temozolomide—skin cancer	0.000385	0.00374	CcSEcCtD
Ketotifen—Body temperature increased—Temozolomide—skin cancer	0.000385	0.00374	CcSEcCtD
Ketotifen—Pain—Fluorouracil—skin cancer	0.000384	0.00373	CcSEcCtD
Ketotifen—Diarrhoea—Dactinomycin—skin cancer	0.000368	0.00358	CcSEcCtD
Ketotifen—Vomiting—Bleomycin—skin cancer	0.000367	0.00357	CcSEcCtD
Ketotifen—Rash—Bleomycin—skin cancer	0.000364	0.00354	CcSEcCtD
Ketotifen—Dermatitis—Bleomycin—skin cancer	0.000364	0.00354	CcSEcCtD
Ketotifen—Urticaria—Fluorouracil—skin cancer	0.000357	0.00347	CcSEcCtD
Ketotifen—Syncope—Docetaxel—skin cancer	0.000356	0.00346	CcSEcCtD
Ketotifen—Body temperature increased—Fluorouracil—skin cancer	0.000355	0.00345	CcSEcCtD
Ketotifen—Loss of consciousness—Docetaxel—skin cancer	0.000349	0.00339	CcSEcCtD
Ketotifen—Pruritus—Temozolomide—skin cancer	0.000345	0.00335	CcSEcCtD
Ketotifen—Nausea—Bleomycin—skin cancer	0.000343	0.00334	CcSEcCtD
Ketotifen—Hypertension—Docetaxel—skin cancer	0.000343	0.00333	CcSEcCtD
Ketotifen—Vomiting—Dactinomycin—skin cancer	0.000342	0.00333	CcSEcCtD
Ketotifen—Rash—Dactinomycin—skin cancer	0.00034	0.0033	CcSEcCtD
Ketotifen—Diarrhoea—Temozolomide—skin cancer	0.000333	0.00324	CcSEcCtD
Ketotifen—Dry mouth—Docetaxel—skin cancer	0.00033	0.00321	CcSEcCtD
Ketotifen—HRH1—lymph node—skin cancer	0.000324	0.00272	CbGeAlD
Ketotifen—Dizziness—Temozolomide—skin cancer	0.000322	0.00313	CcSEcCtD
Ketotifen—Infection—Docetaxel—skin cancer	0.000322	0.00313	CcSEcCtD
Ketotifen—Nausea—Dactinomycin—skin cancer	0.00032	0.00311	CcSEcCtD
Ketotifen—Shock—Docetaxel—skin cancer	0.000319	0.0031	CcSEcCtD
Ketotifen—Pruritus—Fluorouracil—skin cancer	0.000318	0.00309	CcSEcCtD
Ketotifen—Thrombocytopenia—Docetaxel—skin cancer	0.000317	0.00308	CcSEcCtD
Ketotifen—Vomiting—Temozolomide—skin cancer	0.00031	0.00301	CcSEcCtD
Ketotifen—Rash—Temozolomide—skin cancer	0.000307	0.00299	CcSEcCtD
Ketotifen—Diarrhoea—Fluorouracil—skin cancer	0.000307	0.00299	CcSEcCtD
Ketotifen—Dermatitis—Temozolomide—skin cancer	0.000307	0.00298	CcSEcCtD
Ketotifen—Headache—Temozolomide—skin cancer	0.000305	0.00297	CcSEcCtD
Ketotifen—Dizziness—Fluorouracil—skin cancer	0.000297	0.00289	CcSEcCtD
Ketotifen—Insomnia—Docetaxel—skin cancer	0.000293	0.00285	CcSEcCtD
Ketotifen—Paraesthesia—Docetaxel—skin cancer	0.000291	0.00283	CcSEcCtD
Ketotifen—Nausea—Temozolomide—skin cancer	0.000289	0.00281	CcSEcCtD
Ketotifen—Somnolence—Docetaxel—skin cancer	0.000288	0.0028	CcSEcCtD
Ketotifen—Vomiting—Fluorouracil—skin cancer	0.000285	0.00278	CcSEcCtD
Ketotifen—Rash—Fluorouracil—skin cancer	0.000283	0.00275	CcSEcCtD
Ketotifen—Dermatitis—Fluorouracil—skin cancer	0.000283	0.00275	CcSEcCtD
Ketotifen—Headache—Fluorouracil—skin cancer	0.000281	0.00273	CcSEcCtD
Ketotifen—Pain—Docetaxel—skin cancer	0.000277	0.00269	CcSEcCtD
Ketotifen—Nausea—Fluorouracil—skin cancer	0.000267	0.00259	CcSEcCtD
Ketotifen—Gastrointestinal pain—Docetaxel—skin cancer	0.000265	0.00258	CcSEcCtD
Ketotifen—Abdominal pain—Docetaxel—skin cancer	0.000256	0.00249	CcSEcCtD
Ketotifen—Body temperature increased—Docetaxel—skin cancer	0.000256	0.00249	CcSEcCtD
Ketotifen—Pruritus—Docetaxel—skin cancer	0.000229	0.00223	CcSEcCtD
Ketotifen—Diarrhoea—Docetaxel—skin cancer	0.000222	0.00216	CcSEcCtD
Ketotifen—Dizziness—Docetaxel—skin cancer	0.000214	0.00208	CcSEcCtD
Ketotifen—Vomiting—Docetaxel—skin cancer	0.000206	0.002	CcSEcCtD
Ketotifen—Rash—Docetaxel—skin cancer	0.000204	0.00199	CcSEcCtD
Ketotifen—Dermatitis—Docetaxel—skin cancer	0.000204	0.00198	CcSEcCtD
Ketotifen—Headache—Docetaxel—skin cancer	0.000203	0.00197	CcSEcCtD
Ketotifen—Nausea—Docetaxel—skin cancer	0.000192	0.00187	CcSEcCtD
Ketotifen—PDE4A—G Protein Signaling Pathways—KRAS—skin cancer	0.000186	0.00282	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—MC1R—skin cancer	0.000182	0.00277	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—SUFU—skin cancer	0.000182	0.00276	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—MC1R—skin cancer	0.000181	0.00275	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—GLI1—skin cancer	0.000178	0.00271	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—PTCH2—skin cancer	0.000178	0.0027	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—MC1R—skin cancer	0.000174	0.00264	CbGpPWpGaD
Ketotifen—PDE4B—G Protein Signaling Pathways—KRAS—skin cancer	0.000172	0.00261	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—SUFU—skin cancer	0.000169	0.00257	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.000169	0.00256	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—MC1R—skin cancer	0.000169	0.00256	CbGpPWpGaD
Ketotifen—PDE4D—G Protein Signaling Pathways—HRAS—skin cancer	0.000166	0.00252	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—MC1R—skin cancer	0.000166	0.00251	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTCH2—skin cancer	0.000163	0.00248	CbGpPWpGaD
Ketotifen—PGD—Disease—SHH—skin cancer	0.000158	0.0024	CbGpPWpGaD
Ketotifen—PGD—Disease—ENO2—skin cancer	0.000158	0.0024	CbGpPWpGaD
Ketotifen—PDE4A—G Protein Signaling Pathways—HRAS—skin cancer	0.000158	0.0024	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—SHH—skin cancer	0.000156	0.00236	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—SHH—skin cancer	0.000156	0.00236	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—RASA1—skin cancer	0.000155	0.00235	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—RASA1—skin cancer	0.000155	0.00235	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—MC1R—skin cancer	0.000153	0.00232	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—PTCH1—skin cancer	0.000148	0.00224	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—SMO—skin cancer	0.000148	0.00224	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—PTCH1—skin cancer	0.000148	0.00224	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—SMO—skin cancer	0.000148	0.00224	CbGpPWpGaD
Ketotifen—PDE4B—G Protein Signaling Pathways—HRAS—skin cancer	0.000146	0.00222	CbGpPWpGaD
Ketotifen—PDE4C—GPCR downstream signaling—PTGER4—skin cancer	0.000145	0.0022	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—PTGER4—skin cancer	0.000144	0.00218	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—PTGER4—skin cancer	0.000144	0.00218	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—SHH—skin cancer	0.000142	0.00216	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTCH2—skin cancer	0.000142	0.00216	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—SHH—skin cancer	0.000139	0.00211	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—RASA1—skin cancer	0.000138	0.00209	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTCH2—skin cancer	0.000135	0.00205	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—PTCH1—skin cancer	0.000135	0.00205	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—SMO—skin cancer	0.000135	0.00205	CbGpPWpGaD
Ketotifen—PGD—Metabolism—ENO2—skin cancer	0.000133	0.00201	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—PTCH1—skin cancer	0.000132	0.002	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—SMO—skin cancer	0.000132	0.002	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—PTGER4—skin cancer	0.000131	0.00199	CbGpPWpGaD
Ketotifen—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.00013	0.00197	CbGpPWpGaD
Ketotifen—PGD—Disease—FOXO4—skin cancer	0.000129	0.00196	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—SHH—skin cancer	0.000129	0.00196	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—MC1R—skin cancer	0.000129	0.00195	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—RASA1—skin cancer	0.000128	0.00195	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—PTGER4—skin cancer	0.000128	0.00194	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—FOXO4—skin cancer	0.000127	0.00193	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—FOXO4—skin cancer	0.000127	0.00193	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—PTGER4—skin cancer	0.000126	0.00191	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTCH2—skin cancer	0.000125	0.0019	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—SHH—skin cancer	0.000124	0.00188	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—GLI2—skin cancer	0.000124	0.00188	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PTCH1—skin cancer	0.000122	0.00186	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—SMO—skin cancer	0.000122	0.00186	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—PTGER4—skin cancer	0.00012	0.00182	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—PTGER4—skin cancer	0.000119	0.00181	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MC1R—skin cancer	0.000118	0.00179	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—SHH—skin cancer	0.000118	0.00179	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—PTCH1—skin cancer	0.000117	0.00178	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—SMO—skin cancer	0.000117	0.00178	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—GLI1—skin cancer	0.000116	0.00176	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—PTGER4—skin cancer	0.000114	0.00174	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—FOXO4—skin cancer	0.000113	0.00172	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—SMO—skin cancer	0.000112	0.0017	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—PTCH1—skin cancer	0.000112	0.0017	CbGpPWpGaD
Ketotifen—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000111	0.00169	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—PTGER4—skin cancer	0.000111	0.00168	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RHOU—skin cancer	0.00011	0.00168	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—SUFU—skin cancer	0.00011	0.00167	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—SHH—skin cancer	0.000109	0.00166	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—PTGER4—skin cancer	0.000109	0.00165	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—GLI2—skin cancer	0.000108	0.00163	CbGpPWpGaD
Ketotifen—PDE4D—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000106	0.0016	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—FOXO4—skin cancer	0.000105	0.0016	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—PTCH1—skin cancer	0.000103	0.00157	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—SMO—skin cancer	0.000103	0.00157	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MC1R—skin cancer	0.000103	0.00156	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—GLI2—skin cancer	0.000103	0.00156	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—GLI1—skin cancer	0.000101	0.00154	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—PTGER4—skin cancer	0.000101	0.00153	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MC1R—skin cancer	9.78e-05	0.00148	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—GLI1—skin cancer	9.64e-05	0.00146	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SUFU—skin cancer	9.6e-05	0.00146	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—GLI2—skin cancer	9.48e-05	0.00144	CbGpPWpGaD
Ketotifen—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	9.3e-05	0.00141	CbGpPWpGaD
Ketotifen—PGD—Disease—ERCC2—skin cancer	9.2e-05	0.0014	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—SHH—skin cancer	9.16e-05	0.00139	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SUFU—skin cancer	9.14e-05	0.00139	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PTCH2—skin cancer	9.13e-05	0.00139	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MC1R—skin cancer	9.05e-05	0.00137	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—GLI1—skin cancer	8.92e-05	0.00135	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—SMO—skin cancer	8.69e-05	0.00132	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—PTCH1—skin cancer	8.69e-05	0.00132	CbGpPWpGaD
Ketotifen—PGD—Disease—TERT—skin cancer	8.63e-05	0.00131	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—TERT—skin cancer	8.48e-05	0.00129	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—TERT—skin cancer	8.48e-05	0.00129	CbGpPWpGaD
Ketotifen—HRH1—GPCR ligand binding—PTGER4—skin cancer	8.46e-05	0.00128	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SUFU—skin cancer	8.45e-05	0.00128	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—SHH—skin cancer	8.41e-05	0.00128	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—RASA1—skin cancer	8.36e-05	0.00127	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—SMO—skin cancer	7.97e-05	0.00121	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTCH1—skin cancer	7.97e-05	0.00121	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTGER4—skin cancer	7.76e-05	0.00118	CbGpPWpGaD
Ketotifen—PGD—Metabolism—ERCC2—skin cancer	7.71e-05	0.00117	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TERT—skin cancer	7.56e-05	0.00115	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SHH—skin cancer	7.32e-05	0.00111	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—RASA1—skin cancer	7.27e-05	0.0011	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—MC1R—skin cancer	7.27e-05	0.0011	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—NRAS—skin cancer	7.14e-05	0.00108	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—NRAS—skin cancer	7.14e-05	0.00108	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TERT—skin cancer	7.03e-05	0.00107	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SHH—skin cancer	6.97e-05	0.00106	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SMO—skin cancer	6.94e-05	0.00105	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTCH1—skin cancer	6.94e-05	0.00105	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—RASA1—skin cancer	6.92e-05	0.00105	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—FOXO4—skin cancer	6.86e-05	0.00104	CbGpPWpGaD
Ketotifen—PGD—Disease—BRAF—skin cancer	6.83e-05	0.00104	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTGER4—skin cancer	6.76e-05	0.00103	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—BRAF—skin cancer	6.71e-05	0.00102	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—BRAF—skin cancer	6.71e-05	0.00102	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTCH1—skin cancer	6.61e-05	0.001	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SMO—skin cancer	6.61e-05	0.001	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—MC1R—skin cancer	6.6e-05	0.001	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SHH—skin cancer	6.45e-05	0.000978	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTGER4—skin cancer	6.43e-05	0.000976	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—RASA1—skin cancer	6.41e-05	0.000972	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—NRAS—skin cancer	6.37e-05	0.000966	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—KRAS—skin cancer	6.15e-05	0.000933	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—KRAS—skin cancer	6.15e-05	0.000933	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SMO—skin cancer	6.11e-05	0.000927	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTCH1—skin cancer	6.11e-05	0.000927	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—BRAF—skin cancer	5.98e-05	0.000908	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—FOXO4—skin cancer	5.97e-05	0.000906	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTGER4—skin cancer	5.95e-05	0.000903	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—NRAS—skin cancer	5.92e-05	0.000898	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—FOXO4—skin cancer	5.68e-05	0.000862	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—BRAF—skin cancer	5.56e-05	0.000844	CbGpPWpGaD
Ketotifen—PGD—Disease—PTGS2—skin cancer	5.52e-05	0.000837	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—KRAS—skin cancer	5.48e-05	0.000832	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTCH2—skin cancer	5.39e-05	0.000818	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—FOXO4—skin cancer	5.26e-05	0.000798	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—HRAS—skin cancer	5.23e-05	0.000793	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—HRAS—skin cancer	5.23e-05	0.000793	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—KRAS—skin cancer	5.09e-05	0.000773	CbGpPWpGaD
Ketotifen—PDE8B—Signaling by GPCR—IL6—skin cancer	5e-05	0.000759	CbGpPWpGaD
Ketotifen—PDE8A—Signaling by GPCR—IL6—skin cancer	5e-05	0.000759	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PTGER4—skin cancer	4.78e-05	0.000725	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—SHH—skin cancer	4.7e-05	0.000714	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—HRAS—skin cancer	4.66e-05	0.000707	CbGpPWpGaD
Ketotifen—PGD—Metabolism—PTGS2—skin cancer	4.62e-05	0.000701	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TERT—skin cancer	4.58e-05	0.000695	CbGpPWpGaD
Ketotifen—PDE7B—Signaling by GPCR—IL6—skin cancer	4.46e-05	0.000676	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PTCH1—skin cancer	4.46e-05	0.000676	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—SMO—skin cancer	4.46e-05	0.000676	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	4.4e-05	0.000668	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PTGER4—skin cancer	4.34e-05	0.000659	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—HRAS—skin cancer	4.33e-05	0.000657	CbGpPWpGaD
Ketotifen—PGD—Disease—NRAS—skin cancer	4.29e-05	0.000652	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—NRAS—skin cancer	4.22e-05	0.00064	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—NRAS—skin cancer	4.22e-05	0.00064	CbGpPWpGaD
Ketotifen—PDE7A—Signaling by GPCR—IL6—skin cancer	4.14e-05	0.000629	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GLI2—skin cancer	4.09e-05	0.00062	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TERT—skin cancer	3.99e-05	0.000605	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MC1R—skin cancer	3.9e-05	0.000592	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—NRAS—skin cancer	3.86e-05	0.000585	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—GLI1—skin cancer	3.84e-05	0.000583	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TERT—skin cancer	3.79e-05	0.000576	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	3.79e-05	0.000575	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—NRAS—skin cancer	3.76e-05	0.000571	CbGpPWpGaD
Ketotifen—PGD—Disease—KRAS—skin cancer	3.7e-05	0.000561	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SUFU—skin cancer	3.64e-05	0.000553	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—KRAS—skin cancer	3.63e-05	0.000551	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—KRAS—skin cancer	3.63e-05	0.000551	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—BRAF—skin cancer	3.63e-05	0.00055	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TERT—skin cancer	3.51e-05	0.000533	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—NRAS—skin cancer	3.5e-05	0.000531	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—NRAS—skin cancer	3.36e-05	0.00051	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—KRAS—skin cancer	3.32e-05	0.000504	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—KRAS—skin cancer	3.24e-05	0.000491	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—TP53—skin cancer	3.23e-05	0.00049	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—TP53—skin cancer	3.23e-05	0.00049	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	3.22e-05	0.000489	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—NRAS—skin cancer	3.2e-05	0.000485	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—BRAF—skin cancer	3.16e-05	0.000479	CbGpPWpGaD
Ketotifen—PGD—Disease—HRAS—skin cancer	3.14e-05	0.000477	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—HRAS—skin cancer	3.09e-05	0.000468	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—HRAS—skin cancer	3.09e-05	0.000468	CbGpPWpGaD
Ketotifen—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	3.08e-05	0.000468	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—KRAS—skin cancer	3.01e-05	0.000457	CbGpPWpGaD
Ketotifen—PGD—Disease—IL6—skin cancer	3.01e-05	0.000456	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—BRAF—skin cancer	3e-05	0.000456	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—NRAS—skin cancer	2.96e-05	0.000449	CbGpPWpGaD
Ketotifen—PDE8B—Signaling Pathways—IL6—skin cancer	2.95e-05	0.000448	CbGpPWpGaD
Ketotifen—PDE8A—Signaling Pathways—IL6—skin cancer	2.95e-05	0.000448	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—KRAS—skin cancer	2.89e-05	0.000439	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—TP53—skin cancer	2.88e-05	0.000437	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—HRAS—skin cancer	2.82e-05	0.000428	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—BRAF—skin cancer	2.78e-05	0.000422	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SHH—skin cancer	2.78e-05	0.000422	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RASA1—skin cancer	2.76e-05	0.000419	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—HRAS—skin cancer	2.75e-05	0.000418	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—KRAS—skin cancer	2.75e-05	0.000417	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—IL6—skin cancer	2.7e-05	0.00041	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—TP53—skin cancer	2.67e-05	0.000406	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—IL6—skin cancer	2.63e-05	0.0004	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SMO—skin cancer	2.63e-05	0.0004	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTCH1—skin cancer	2.63e-05	0.0004	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTGER4—skin cancer	2.56e-05	0.000389	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—HRAS—skin cancer	2.56e-05	0.000388	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—KRAS—skin cancer	2.55e-05	0.000386	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—HRAS—skin cancer	2.46e-05	0.000373	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—IL6—skin cancer	2.45e-05	0.000372	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—IL6—skin cancer	2.35e-05	0.000357	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—HRAS—skin cancer	2.34e-05	0.000355	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—NRAS—skin cancer	2.28e-05	0.000346	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FOXO4—skin cancer	2.26e-05	0.000344	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—IL6—skin cancer	2.24e-05	0.00034	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—HRAS—skin cancer	2.16e-05	0.000328	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—IL6—skin cancer	2.07e-05	0.000314	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—NRAS—skin cancer	1.98e-05	0.000301	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KRAS—skin cancer	1.96e-05	0.000298	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—NRAS—skin cancer	1.89e-05	0.000287	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—NRAS—skin cancer	1.75e-05	0.000265	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TP53—skin cancer	1.74e-05	0.000265	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KRAS—skin cancer	1.71e-05	0.000259	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—HRAS—skin cancer	1.67e-05	0.000253	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KRAS—skin cancer	1.63e-05	0.000247	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL6—skin cancer	1.6e-05	0.000242	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TP53—skin cancer	1.52e-05	0.00023	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TERT—skin cancer	1.51e-05	0.00023	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KRAS—skin cancer	1.5e-05	0.000228	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—HRAS—skin cancer	1.45e-05	0.00022	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TP53—skin cancer	1.44e-05	0.000219	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL6—skin cancer	1.39e-05	0.000211	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—HRAS—skin cancer	1.38e-05	0.00021	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TP53—skin cancer	1.34e-05	0.000203	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL6—skin cancer	1.32e-05	0.000201	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—HRAS—skin cancer	1.28e-05	0.000194	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—NRAS—skin cancer	1.27e-05	0.000193	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL6—skin cancer	1.22e-05	0.000186	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—BRAF—skin cancer	1.2e-05	0.000182	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—KRAS—skin cancer	1.1e-05	0.000166	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—HRAS—skin cancer	9.32e-06	0.000141	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL6—skin cancer	8.92e-06	0.000135	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NRAS—skin cancer	7.53e-06	0.000114	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KRAS—skin cancer	6.48e-06	9.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TP53—skin cancer	5.76e-06	8.74e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HRAS—skin cancer	5.51e-06	8.36e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL6—skin cancer	5.27e-06	8e-05	CbGpPWpGaD
